Harpoon Therapeutics Investor Relations Material
Latest events
Study Update
Harpoon Therapeutics
Corporate Presentation
1 Dec, 2023
Q3 2023
9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harpoon Therapeutics Inc
Access all reports
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company engaged in the development of innovative T cell engagers. These engagers are designed to harness the power of the body's immune system to treat patients suffering from cancer and other diseases.The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
HARP
Country
🇺🇸 United States